CVS Health (NYSE:CVS) Price Target Raised to $73.00

CVS Health (NYSE:CVSFree Report) had its price target hoisted by Barclays from $71.00 to $73.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has an overweight rating on the pharmacy operator’s stock.

A number of other equities research analysts have also issued reports on the company. Leerink Partners raised CVS Health from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $55.00 to $75.00 in a research note on Thursday. Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. Cantor Fitzgerald raised CVS Health from a “neutral” rating to an “overweight” rating in a research note on Wednesday. TD Cowen raised their price target on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. Finally, Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price for the company in a research report on Tuesday, December 3rd. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average price target of $70.28.

Get Our Latest Analysis on CVS

CVS Health Stock Down 1.0 %

NYSE CVS opened at $65.71 on Thursday. The stock’s 50-day moving average price is $51.11 and its 200-day moving average price is $56.08. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health has a 52 week low of $43.56 and a 52 week high of $80.75. The company has a market capitalization of $82.68 billion, a P/E ratio of 16.68, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61.

CVS Health (NYSE:CVSGet Free Report) last released its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. On average, equities research analysts predict that CVS Health will post 5.14 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.05%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio is presently 67.51%.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the business. Norges Bank acquired a new stake in shares of CVS Health during the 4th quarter worth $839,574,000. Capital World Investors increased its holdings in shares of CVS Health by 26.6% during the 4th quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator’s stock worth $2,739,927,000 after buying an additional 12,819,148 shares during the last quarter. Davis Selected Advisers increased its holdings in shares of CVS Health by 2,998.1% during the 4th quarter. Davis Selected Advisers now owns 11,385,950 shares of the pharmacy operator’s stock worth $511,115,000 after buying an additional 11,018,438 shares during the last quarter. Dodge & Cox increased its holdings in shares of CVS Health by 11.2% during the 4th quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator’s stock worth $3,147,054,000 after buying an additional 7,075,209 shares during the last quarter. Finally, Pzena Investment Management LLC increased its holdings in shares of CVS Health by 49.3% during the 4th quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator’s stock worth $880,319,000 after buying an additional 6,475,271 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

(Get Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Read More

Analyst Recommendations for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.